Strategy Notes
The EIC Accelerator offers non-dilutive funding up to €2.5M, matching the venture's target range and stage. The venture's AI/biotech focus and planned partnerships with French pharma align well with EU innovation priorities, though the current AUROC of 0.634 may need improvement to be competitive.